Laura Montejano

990 total citations
7 papers, 300 citations indexed

About

Laura Montejano is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Laura Montejano has authored 7 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Laura Montejano's work include Multiple Myeloma Research and Treatments (6 papers), Glycosylation and Glycoproteins Research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Laura Montejano is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Glycosylation and Glycoproteins Research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Laura Montejano collaborates with scholars based in Spain. Laura Montejano's co-authors include Juan José Lahuerta, Jesús F. San Miguel, Alberto Órfão, Joaquı́n Dı́az-Mediavilla, Javier de la Rubia, Norma C. Gutiérrez, Gema Mateo, Anna Sureda, Luis Palomera and María‐Belén Vídriales and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Haematology.

In The Last Decade

Laura Montejano

7 papers receiving 292 citations

Peers

Laura Montejano

HEMAT

MB

ONCOL

GENET

IMMUN

María-Ángeles Montalbán Spain

Pauline Huyghe France

Scott VanWier United States

Sabrina Pechtel Germany

Mélanie Pannetier France

Maria Krevvata United States

Kyle A. Udd United States

Raphael Teipel Germany

Lüder Hinrich Meyer Germany

Anna Truppel-Hartmann United States

María-Ángeles Montalbán Spain

Laura Montejano

276 ×1.1

HEMAT

217 ×1.5

MB

178 ×1.2

ONCOL

69 ×0.8

GENET

40 ×0.9

IMMUN

Citations per year, relative to Laura Montejano Laura Montejano (= 1×) peers María-Ángeles Montalbán

Countries citing papers authored by Laura Montejano

Since Specialization

Citations

This map shows the geographic impact of Laura Montejano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Montejano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Montejano more than expected).

Fields of papers citing papers by Laura Montejano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Montejano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Montejano. The network helps show where Laura Montejano may publish in the future.

Co-authorship network of co-authors of Laura Montejano

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Montejano. A scholar is included among the top collaborators of Laura Montejano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Montejano. Laura Montejano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Carreño‐Tarragona, Gonzalo, María‐Teresa Cedena, Laura Montejano, et al.. (2018). Papain‐treated panels are a simple method for the identification of alloantibodies in multiple myeloma patients treated with anti‐CD38‐based therapies. Transfusion Medicine. 29(3). 193–196. 13 indexed citations

2.

Martínez‐López, Joaquín, Ramón García‐Sánz, François Pépin, et al.. (2013). Prognostic value of deep sequencing method for minimal residual disease (MRD) detection in multiple myeloma.. Journal of Clinical Oncology. 31(15_suppl). 8511–8511. 2 indexed citations

3.

Segura, Gloria Pérez, et al.. (2012). Hemolytic Disease of the Newborn Due to Anti-Jkb: Case Report and Review of the Literature. Indian Journal of Hematology and Blood Transfusion. 30(2). 135–138. 8 indexed citations

4.

Rapado, Inmaculada, et al.. (2012). New antimyeloma drugs in spinal cord infiltration for multiple myeloma. Determination of lenalidomide in cerebrospinal fluid with ultrasensitive high-performance liquid chromatography. 1(2). 11–13. 1 indexed citations

5.

Martínez‐Sánchez, Pilar, Laura Montejano, María Eugenia Sarasquete, et al.. (2008). Evaluation of minimal residual disease in multiple myeloma patients by fluorescent‐polymerase chain reaction: the prognostic impact of achieving molecular response. British Journal of Haematology. 142(5). 766–774. 39 indexed citations

6.

Mateo, Gema, María-Ángeles Montalbán, María‐Belén Vídriales, et al.. (2008). Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy. Journal of Clinical Oncology. 26(16). 2737–2744. 150 indexed citations

7.

Mateo, Gema, Ana Rasillo, Norma C. Gutiérrez, et al.. (2005). Genetic Abnormalities and Patterns of Antigenic Expression in Multiple Myeloma. Clinical Cancer Research. 11(10). 3661–3667. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact